IraShafranMDAGAF

Gastroenterology • Winter Park, FL

Inflammatory Bowel Disease

Director Shafran Gastroenterology Research

Join to view full profile

Dr. Shafran is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shafran's full profile

Already have an account?

Office
1004 Temple Grv
Winter Park, FL 32789
Phone+1 407-310-5520

Fax+1 407-539-2242

Summary

I am a clinical researcher devoted to the study of inflammatory bowel disease.
Our website can be seen at www.shafran.net
Please look at our site to visit our wonderful practice and our experience in pivotal clinical trials to help our IBD patients.

Education & Training

Ohio State University HospitalFellowship, Gastroenterology, 1977 - 1979
Ohio State University HospitalResidency, Internal Medicine, 1975 - 1977
Ohio State University HospitalInternship, Internal Medicine, 1974 - 1975
Ohio State University College of MedicineClass of 1974

Certifications & Licensure

FL State Medical License 1979 - 2020
AGAAGAF

Awards, Honors, & Recognition

Top Doctors: Florida Castle Connolly, 2000-2014
Top MD Consumers Checkbook

Clinical Trials

Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy Start of enrollment: 2010 Jan 01
Completed
Not Applicable
Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
Completed
Phase 2

Publications & Presentations

PubMed

2 citations
Cytokine expression in subjects withssp.positive blood cultures and a meta-analysis of cytokine expression in Crohn's disease.
J Todd Kuenstner, Qiang Xu, Tim J Bull, Antonio C G Foddai, Irene R Grant
Frontiers in Cellular and Infection Microbiology. 2024-01-01
54 citations
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, ran...
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie D. Long, Matthieu Allez
The Lancet. Gastroenterology & Hepatology. 2021-11-17
40 citations
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3...
Severine Vermeire, Peter L. Lakatos, Timothy Ritter, Stephen B. Hanauer, Brian Bressler
The Lancet. Gastroenterology & Hepatology. 2021-11-16

Journal Articles

Utility of Video Capsule Endoscopy for Longitudinal Monitoring of Crohn’s Disease Activity in the Small Bowel: A Prospective Study
Gil Y Melmed, Marla C Dubinsky, David T Rubin, Shabana F Pasha, Atsushi Sakuraba, Felix Tiongco, Ira Shafran, Jonathan A Leighton, Gastrointestinal Endoscopy

Press Mentions

Diverticulitis Causes and Risk FactorsSeptember 30th, 2022

Professional Memberships